Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Exciting Additions to Goodwin’s Data + Privacy + Cybersecurity Group

Related Content

California Invasion of Privacy Act (CIPA) Decisions Continue to Create Uncertainty for Websites Using Third-Party Technology

EU/UK Privacy & Cybersecurity News Roundup – Week of June 5, 2023

EU/UK Privacy & Cybersecurity News Roundup – Week of May 30, 2023

Top IP, FDA, and Compliance Issues for Medtech Companies Transitioning to Data-Enabled Product Solutions

EU AI Act: Foundation Models and Almost at the Finish Line

EU/UK Privacy & Cybersecurity News Roundup – Week of May 22, 2023

Washington’s Biometric Data Regime Advances Privacy Regulation

EU/UK Privacy & Cybersecurity News Roundup – Week of May 15, 2023

Broader State Scrutiny of Consumer Health Data Tests Companies (Bloomberg Law)

Chambers USA 2023 Recognizes 77 Practices and 167 Lawyers

Bev Acquired by E. & J. Gallo Winery

Securities and Exchange Commission to Impose Significant New Privacy and Cybersecurity Rules (The Journal of Federal Agency Action)

Washington’s Biometric Data Regime Advances Privacy Regulation (Bloomberg Law)

Takeaways From Washington's Sweeping Health Privacy Bill (Law360)

Subject Matter and Kivvit Combine to Create National Communications and Advocacy Powerhouse

Magenta Therapeutics To Combine With Dianthus Therapeutics In All-Stock Transaction

Data, Privacy & Cybersecurity